Abnormal Placenta Plant Disease Early Diagnosis and Individualized Treatment Research
NCT ID: NCT02946749
Last Updated: 2017-08-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
3000 participants
OBSERVATIONAL
2016-12-31
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ultrasound Elastography Application in Cesarean Section Scar Defect
NCT05363735
Risk Factors, Prognosis and Prediction Models for Placenta Accreta Without Prior Cesarean Section
NCT06383923
Prospective Cohort Observational Study of Placenta Accreta Spectrum Disorders
NCT06021964
Comparison Between Hysterectomy and Conservative Management in Treatment of Placenta Accreta Regarding Maternal Complication
NCT03327818
The Application of Comprehensive Prevention and Treatment Strategy of Placenta Accreta Spectrum Disorders
NCT06477497
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Shanghai First Maternity and Infant Hospital
No interventions assigned to this group
the Putuo District Maternity and Child Health Care Hospital
No interventions assigned to this group
the Xinhua hospital affiliated to Shanghai jiaotong University
No interventions assigned to this group
The Sixth people's hospital of Shanghai
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* see a doctor before gestational 8 weeks in our study center
* will continue to pregnancy, high patient compliance
Exclusion Criteria
* hysteromyoma or adenomyoma stripping history
* history of intrauterine adhesions
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai First Maternity and Infant Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hao Ying, PHD
Role: PRINCIPAL_INVESTIGATOR
Shanghai First Maternity and Infant Hospital
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Yinghao
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.